Keywords: Glycosite Analysis, Glycoproteomics, Mass Spectrometry, Glycosite, Enrichment, De-glycosylation, Intact glycopeptides, Quantification, Collision-inducced dissociation (CID), Electron transfer dissociation (ETD), Multistage tandem MS (MSn), Post-translational modifications, Covalent modifications, Numerous Cellular Processes, Glycoproteins, Post Proteomic er, N-linked glycans, Sugar structure elucidation, Micro-heterogeneity, Coexisting non-glycoproteins/peptides, Mammalian lectins, Galectins, selectins, Chemo-enzymatic labeling, De-Glycosylation Methods, O-GlcNAc modifcation, Beta-elemination, Michael addition, Dithiothreitol, Multiple lectin-mediated, Hydrazide chemistry, Non-redundant glycoproteins, Subproteome, O-GlcNAc Site, Mucin-type O-Glycosites, Electron Capture Dissociation (ECD), Infrared multiphoton dissociation (IRMPD), ETD/ECD Assisted Glycosite, Labeling based Quantification, Label-free Quantification, Immuno-enriched, BAP= Biotin pentylamine, ESI=Electrospray ionization, CDK=Climatic droplet keratopathy, CSC=Cell surface capturing, CRC=Colorectal cancer
Current Proteomics
Title: Editorial:[Special Issue: Post-Translational Proteomics and its Application (Guest Editor: Qing-Yu He)]
Volume: 7 Issue: 3
Author(s): Qing-Yu He
Affiliation:
Keywords: Glycosite Analysis, Glycoproteomics, Mass Spectrometry, Glycosite, Enrichment, De-glycosylation, Intact glycopeptides, Quantification, Collision-inducced dissociation (CID), Electron transfer dissociation (ETD), Multistage tandem MS (MSn), Post-translational modifications, Covalent modifications, Numerous Cellular Processes, Glycoproteins, Post Proteomic er, N-linked glycans, Sugar structure elucidation, Micro-heterogeneity, Coexisting non-glycoproteins/peptides, Mammalian lectins, Galectins, selectins, Chemo-enzymatic labeling, De-Glycosylation Methods, O-GlcNAc modifcation, Beta-elemination, Michael addition, Dithiothreitol, Multiple lectin-mediated, Hydrazide chemistry, Non-redundant glycoproteins, Subproteome, O-GlcNAc Site, Mucin-type O-Glycosites, Electron Capture Dissociation (ECD), Infrared multiphoton dissociation (IRMPD), ETD/ECD Assisted Glycosite, Labeling based Quantification, Label-free Quantification, Immuno-enriched, BAP= Biotin pentylamine, ESI=Electrospray ionization, CDK=Climatic droplet keratopathy, CSC=Cell surface capturing, CRC=Colorectal cancer
Export Options
About this article
Cite this article as:
He Qing-Yu, Editorial:[Special Issue: Post-Translational Proteomics and its Application (Guest Editor: Qing-Yu He)], Current Proteomics 2010; 7 (3) . https://dx.doi.org/10.2174/157016410792928170
DOI https://dx.doi.org/10.2174/157016410792928170 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Therapeutic Potential of Targeting Transforming Growth Factor-beta in Colorectal Cancer: Rational and Progress
Current Pharmaceutical Design Editorial Review 2015
Current Radiopharmaceuticals PPARδ Signaling Regulates Colorectal Cancer
Current Pharmaceutical Design Drug Combinations Enhancing the Antineoplastic Effects of Erlotinib in High-Grade Glioma
Recent Patents on Anti-Cancer Drug Discovery Anticancer Properties of Asian Water Monitor Lizard (Varanus salvator), Python (Malayopython reticulatus) and Tortoise (Cuora kamaroma amboinensis)
Anti-Cancer Agents in Medicinal Chemistry What is the Optimal Treatment for Anemia in Inflammatory Bowel Disease?
Current Drug Delivery Clinical Strategies for the Blockade of IL-18 in Inflammatory Bowel Diseases
Current Drug Targets MUTYH Associated Polyposis (MAP)
Current Genomics Sorafenib (BAY 43-9006): Review of Clinical Development
Current Clinical Pharmacology The Molecular Machinery Regulating Apoptosis Signal Transduction and its Implication in Human Physiology and Pathophysiologies
Current Molecular Medicine Methylation of ZNF331 Promotes Cell Invasion and Migration in Human Esophageal Cancer
Current Protein & Peptide Science Strategies for Increasing the Solubility and Bioavailability of Anticancer Compounds: β-Lapachone and Other Naphthoquinones
Current Pharmaceutical Design Natural Product as Substrates of ABC Transporters: A Review
Recent Patents on Anti-Cancer Drug Discovery Harnessing Polypharmacology with Computer-Aided Drug Design and Systems Biology
Current Pharmaceutical Design Context-dependent Action of Transforming Growth Factor β Family Members on Normal and Cancer Stem Cells
Current Pharmaceutical Design IDO and Clinical Conditions Associated with Depressive Symptoms
Current Drug Metabolism Imaging of Cyclooxygenase-2 (COX-2) Expression: Potential Use in Diagnosis and Drug Evaluation
Current Pharmaceutical Design Recent Clinical Experience with Oncolytic Viruses
Current Pharmaceutical Biotechnology Implication of CYP24A1 Splicing in Breast Cancer
Anti-Cancer Agents in Medicinal Chemistry Aldo-Keto Reductase Family 1 Member B1 Inhibitors: Old Drugs with New Perspectives
Recent Patents on Anti-Cancer Drug Discovery